Evidence map›Paper›PMID 40322347›Full record

ArticleCureus2025

Diabetic Ketoacidosis With Schmidt Syndrome: An Autoimmune Polyendocrine Syndrome Type 2.

Munhill Shahzad, Faheem Zaman

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Munhill ShahzadMedicine, Ayub Teaching Hospital, Abbottabad, PAK.
Faheem ZamanMedicine, Ayub Teaching Hospital, Abbottabad, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schmidt syndrome or autoimmune polyglandular syndrome type 2 is an autoimmune disorder that affects many hormone-producing (endocrine) glands. With the role of genetics and familial predisposition, autoimmune thyroid disease in combination with Addison's disease is the most common presentation. Diabetes mellitus, hyperparathyroidism, pernicious anemia, hypogonadism, vitiligo, chronic atrophic gastritis, chronic autoimmune hepatitis, alopecia, myasthenia gravis, rheumatoid arthritis, Sjögren's syndrome, and thrombocytic purpura may or may not be present. We present a case of a 28-year-old male, already diagnosed with Addison's disease for the past eight years. He presented to our medical department with nausea and vomiting over two days. On presentation, he was lethargic and dehydrated with sunken eyes as well as discoloration of the gums and skin. His abdomen was soft but mildly tender. He had high serum glucose levels and was diagnosed as a case of diabetic ketoacidosis based on urinary ketones and arterial blood gases, after being diagnosed with diabetes two months prior. On further investigation, his thyroid function test was deranged two months ago as well. This syndrome is a rare autoimmune disorder that is difficult to diagnose because its symptoms depend on which gland becomes involved first. The patient was treated and improved with corticosteroids, thyroxine, and insulin therapy.

Indexed as

autoimmune addison’s diseaseautoimmune polyendocrine syndromediabetic ketoacidosisschmidt syndromethyroiditis

Identifiers

PMID40322347
PMCPMC12046195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.